NorthRock Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
NorthRock Partners's BCAT Position: Q2 2026 in Review
NorthRock Partners reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 4.9% in Q2 2026, selling an estimated $16K and leaving 20,236 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #515.
NorthRock Partners first reported a position in BCAT in Q1 2026 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- NorthRock Partners held 20,236 shares of BlackRock Capital Allocation Term Trust worth $322K as of Q2 2026.
- NorthRock Partners sold 1,045 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $16K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #515 holding.
- NorthRock Partners first reported a position in BlackRock Capital Allocation Term Trust in Q1 2026 and has held it in 2 quarters since.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.